Evidence map›Paper›PMID 25963986›Full record

ArticleAntimicrobial agents and chemotherapy2015

Staphylococcus aureus metabolic adaptations during the transition from a daptomycin susceptibility phenotype to a daptomycin nonsusceptibility phenotype.

Rosmarie Gaupp, Shulei Lei, Joseph M Reed, Henrik Peisker, Susan Boyle-Vavra, Arnold S Bayer, Markus Bischoff, Mathias Herrmann, Robert S Daum, Robert Powers and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Rhein againstCurrent research in food science · 2024
    Article
  7. Review
  8. Article
  9. Membrane Phenotypic, Metabolic and Genotypic Adaptations ofAntibiotics (Basel, Switzerland) · 2023
    Article
  10. Mild magnetic hyperthermia is synergistic with an antibiotic treatment against dual species biofilms consisting ofInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2023
    Article
  11. Article
  12. Transcriptomics and Metabolomics Analysis ofFoods (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Article
  15. Respiratory Depression as Antibacterial Mechanism of Linalool againstInternational journal of molecular sciences · 2022
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Rosmarie GauppSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Shulei LeiDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Joseph M ReedSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Henrik PeiskerInstitute of Medical Microbiology and Hygiene, University of Saarland, Homburg/Saar, Germany.
Susan Boyle-VavraDepartment of Pediatrics, University of Chicago, Chicago, Illinois, USA.
Arnold S BayerDivision of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.
Markus BischoffInstitute of Medical Microbiology and Hygiene, University of Saarland, Homburg/Saar, Germany.
Mathias HerrmannInstitute of Medical Microbiology and Hygiene, University of Saarland, Homburg/Saar, Germany.
Robert S DaumDepartment of Pediatrics, University of Chicago, Chicago, Illinois, USA.
Robert PowersDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA gsomerville3@unl.edu rpowers3@unl.edu.
Greg A SomervilleSchool of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, Nebraska, USA gsomerville3@unl.edu rpowers3@unl.edu.
University of Nebraska–Lincoln · USInstitute of Medical Microbiology and Hygiene · DEUniversity of Chicago · USSaarland University · DEUCLA Medical Center · US

Funding

THE REDOX-MEDIATED REGULATION OF IRON-RESPONSIVE GENE EXPRESSION IN LIVERP20RR017675 · NCRR · UNIVERSITY OF NEBRASKA LINCOLN · PI GRASS, GREGOR · 2002 to 2011
$20.4M
Staphylococcal Adaptations to Platelet Microbicidal ProteinR01AI039108 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI BAYER, ARNOLD S · 1997 to 2016
$5.1M
Redox Biology CenterP30GM103335 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI BECKER, DONALD F · 2012 to 2016
$4.3M
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR015468 · NCRR · UNIVERSITY OF NEBRASKA LINCOLN · PI PAUL, PREM S · 2000 to 2000
$2.0M
Citric acid cycle regulation of exopolysaccharide synthesis in staphylococciR01AI087668 · NIAID · UNIVERSITY OF NEBRASKA LINCOLN · PI SOMERVILLE, GREG ALAN · 2010 to 2013
$1.4M
NCRR NIH HHS C06 RR015468NCRR NIH HHS P20 RR017675NCRR NIH HHS P20 RR-17675NCRR NIH HHS RR01546801NIAID NIH HHS 5R01-AI039108-18NIAID NIH HHS AI087668NIAID NIH HHS AI11176NIAID NIH HHS R01 AI039108NIAID NIH HHS R01 AI087668NIGMS NIH HHS P30 GM103335
6 · The paper itself

Abstract

Staphylococcus aureus is a major cause of nosocomial and community-acquired infections. The success of S. aureus as a pathogen is due in part to its many virulence determinants and resistance to antimicrobials. In particular, methicillin-resistant S. aureus has emerged as a major cause of infections and led to increased use of the antibiotics vancomycin and daptomycin, which has increased the isolation of vancomycin-intermediate S. aureus and daptomycin-nonsusceptible S. aureus strains. The most common mechanism by which S. aureus acquires intermediate resistance to antibiotics is by adapting its physiology and metabolism to permit growth in the presence of these antibiotics, a process known as adaptive resistance. To better understand the physiological and metabolic changes associated with adaptive resistance, six daptomycin-susceptible and -nonsusceptible isogenic strain pairs were examined for changes in growth, competitive fitness, and metabolic alterations. Interestingly, daptomycin nonsusceptibility coincides with a slightly delayed transition to the postexponential growth phase and alterations in metabolism. Specifically, daptomycin-nonsusceptible strains have decreased tricarboxylic acid cycle activity, which correlates with increased synthesis of pyrimidines and purines and increased carbon flow to pathways associated with wall teichoic acid and peptidoglycan biosynthesis. Importantly, these data provided an opportunity to alter the daptomycin nonsusceptibility phenotype by manipulating bacterial metabolism, a first step in developing compounds that target metabolic pathways that can be used in combination with daptomycin to reduce treatment failures.

Indexed as

Aconitate HydrataseAmino AcidsAnti-Bacterial AgentsCell WallCitric Acid CycleDaptomycinDrug Resistance, BacterialMagnetic Resonance SpectroscopyMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsPeptidoglycanPhenotypePurinesPyrimidinesStaphylococcus aureusTeichoic AcidsAconitate HydrataseAmino AcidsAnti-Bacterial AgentsDaptomycinPeptidoglycanPurinesPyrimidinesTeichoic Acids

Identifiers

PMID25963986
PMCPMC4468685
OpenAlexW1480576861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.